Back
BioRestorative Therapies Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
BRTX
BioRestorative Therapies
Last Price:
$1.51
Seasonality Move:
-5.01%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and BRTX is experiencing slight buying pressure.
BioRestorative Therapies Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.48 | Buy |
20-day SMA: | 1.52 | Buy |
50-day SMA: | 1.61 | Sell |
200-day SMA: | 1.71 | Sell |
8-day EMA: | 1.5 | Buy |
20-day EMA: | 1.51 | Buy |
50-day EMA: | 1.58 | Sell |
200-day EMA: | 1.69 | Sell |
BioRestorative Therapies Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 50.94 | Buy |
Chaikin Money Flow: | 11063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.45 - 1.61) | Buy |
Bollinger Bands (100): | (1.55 - 1.81) | Sell |
BioRestorative Therapies Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioRestorative Therapies Stock
Is BioRestorative Therapies Stock a Buy?
-
BioRestorative Therapies share price is 1.54 while BRTX 8-day simple moving average is 1.48, which is a Buy signal.
-
The stock price of BRTX is 1.54 while BioRestorative Therapies 20-day SMA is 1.52, which makes it a Buy.
-
BioRestorative Therapies 50-day simple moving average is 1.61 while BRTX share price is 1.54, making it a Sell technically.
-
BRTX stock price is 1.54 and BioRestorative Therapies 200-day simple moving average is 1.71, creating a Sell signal.
BRTX Technical Analysis vs Fundamental Analysis
Sell
33
BioRestorative Therapies (BRTX)
is a Sell
Is BioRestorative Therapies a Buy or a Sell?
-
BioRestorative Therapies stock is rated a SellThe current BioRestorative Therapies [BRTX] share price is $1.54. The Score for BRTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
BioRestorative Therapies Stock Info
Market Cap:
12.3M
Price in USD:
1.54
Share Volume:
20.5K
BioRestorative Therapies 52-Week Range
52-Week High:
2.55
52-Week Low:
1.21
Sell
33
BioRestorative Therapies (BRTX)
is a Sell
BioRestorative Therapies Share Price Forecast
-
What is the BioRestorative Therapies stock price today?The BioRestorative Therapies stock price is 1.54 USD today.
-
Will BRTX stock go up or go down?BioRestorative Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is BioRestorative Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioRestorative Therapies is overvalued.
Is BioRestorative Therapies Stock a Buy?
-
BioRestorative Therapies share price is 1.54 while BRTX 8-day exponential moving average is 1.50, which is a Buy signal.
-
The stock price of BRTX is 1.54 while BioRestorative Therapies 20-day EMA is 1.51, which makes it a Buy.
-
BioRestorative Therapies 50-day exponential moving average is 1.58 while BRTX share price is 1.54, making it a Sell technically.
-
BRTX stock price is 1.54 and BioRestorative Therapies 200-day simple moving average is 1.69, creating a Sell signal.
Fundamental Analysis of BioRestorative Therapies
Is BioRestorative Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.33 per share.
Technical Analysis of BioRestorative Therapies
Should I short BioRestorative Therapies stock?
-
BRTX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting BioRestorative Therapies is a Sell
-
BioRestorative Therapies Relative Strength Index (RSI) is 50.94, which suggest BioRestorative Therapies is overbought
-
The Bollinger Bands (25) for BioRestorative Therapies is (1.45 - 1.61), which suggest BioRestorative Therapies is a Sell
-
The Bollinger Bands (100) for BioRestorative Therapies is (1.55 - 1.81), which suggest BioRestorative Therapies is a Sell
* BioRestorative Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.